Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sunshine Silver Mining | Thomas S. Kaplan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 2,739,640 | 0 | - | - | Warrant (right to buy) | |
| Sunshine Silver Mining | Thomas S. Kaplan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.87 per share. | 05 Jun 2026 | 2,739,640 | 78,677,940 | - | 2.9 | 7,862,767 | Common Stock |
| Sunshine Silver Mining | Thomas S. Kaplan | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.50 per share. | 05 Jun 2026 | 582,022 | 78,095,918 | - | 13.5 | 7,857,297 | Common Stock |
| Acacia Research Corp | Martin D. McNulty | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 539,160 | 705,563 (1%) | 1% | 0 | ACTG Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 529,568 | 33,364,242 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 529,568 | 33,364,242 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 529,568 | 33,364,242 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 529,568 | 33,364,242 | - | 0 | Class C Common Stock | |
| Verrica Pharma Inc | Jayson Rieger | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 512,269 | 512,269 | - | - | Employee Stock Option (right to buy) | |
| Braze Inc (Class A) | Neeraj Agrawal | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 500,000 | 388,123 | - | 0 | Class A Common Stock | |
| Butterfly Network Inc (Class A) | Steve Cashman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.66 per share. | 05 Jun 2026 | 294,680 | 1,630,407 | - | 4.7 | 1,373,209 | Class A Common Stock |
| Acacia Research Corp | Martin D. McNulty | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.62 per share. | 05 Jun 2026 | 287,133 | 418,430 (0%) | 0% | 4.6 | 1,326,554 | ACTG Common Stock |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 0 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | 0 | Class C Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 264,784 | 264,784 | - | - | LLC Units in TWFG Holding | |
| Robinhood Markets Inc (Class A) | Meyer Rais Malka | Director | Purchase of securities on an exchange or from another person at price $ 80.74 per share. | 05 Jun 2026 | 250,000 | 3,924,427 | - | 80.7 | 20,184,200 | Class A Common Stock |
| Verrica Pharma Inc | Noah L. Rosenberg | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 233,840 | 233,840 | - | - | Employee Stock Option (right to buy) | |
| Cleveland-Cliffs Inc | Celso L. Goncalves | EVP, CFO | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 05 Jun 2026 | 214,308 | 184,541 (0%) | 0% | 13.4 | 2,874,642 | Common Shares |
| PattersonUTI Energy Inc | William Andrew Hendricks | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 11.64 per share. | 05 Jun 2026 | 200,000 | 2,542,474 (1%) | 0% | 11.6 | 2,328,000 | Common Stock |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 177,768 | 177,768 | - | - | Restricted Stock Units | |
| Verrica Pharma Inc | David Zawitz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 171,340 | 171,340 | - | - | Employee Stock Option (right to buy) | |
| Charles River Labs | James C. Foster | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 153,361 | 126,596 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | James C. Foster | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 153,361 | 155,611 (0%) | 0% | 0 | Common Stock | |
| BrightSpring Health Services Inc | Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 130,000 | 1,324,503 | - | 6.4 | 828,100 | Common Stock |
| BrightSpring Health Services Inc | Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 130,000 | 404,676 | - | - | Stock Options (Right to Buy) | |
| BrightSpring Health Services Inc | Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 130,000 | 1,166,064 | - | - | Stock Options (Right to Buy) | |
| BrightSpring Health Services Inc | Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 130,000 | 0 | - | 58.8 | 7,637,500 | Common Stock |
| BrightSpring Health Services Inc | Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 130,000 | 130,000 | - | 6.4 | 828,100 | Common Stock |
| BrightSpring Health Services Inc | Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 130,000 | 1,194,503 | - | 58.8 | 7,637,500 | Common Stock |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.04 per share. | 05 Jun 2026 | 122,500 | 910,706 (1%) | 0% | 14.0 | 1,719,900 | Class A Common Stock |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 122,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ryan Specialty Holdings Inc (Class A) | Patrick G. Ryan | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 32.50 per share. | 05 Jun 2026 | 120,000 | 13,817,859 | - | 32.5 | 3,899,736 | Class A Common Stock |
| Garrett Motion Inc - Ordinary Shares - New | Sean Deason | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 05 Jun 2026 | 110,000 | 261,909 (0%) | 0% | 31.9 | 3,512,597 | Common Stock |
| W & T Offshore Inc | Tracy W. Krohn | Director, Chairman, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 106,667 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Tracy W. Krohn | Director, Chairman, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 106,667 | 1,386,953 (0%) | 0% | - | Common Stock | |
| General Mills | Kofi A. Bruce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 105,581 | 234,679 (0%) | 0% | 0 | Common Stock | |
| Butterfly Network Inc (Class A) | Steve Cashman | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 05 Jun 2026 | 104,781 | 1,925,087 | - | 5.0 | 520,133 | Class A Common Stock |
| AEVEX Corp Ordinary Shares | Brian Raduenz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jun 2026 | 104,722 | 0 | - | - | Series B Units | |
| AEVEX Corp Ordinary Shares | Brian Raduenz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jun 2026 | 104,722 | 0 | - | - | Class B Common Stock | |
| VAALCO Energy Inc | George Walter Mitchell Maxwell | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.29 per share. | 05 Jun 2026 | 100,540 | 1,188,076 (2%) | 0% | 5.3 | 531,857 | Common Stock |
| Arista Networks | Andy Bechtolsheim | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 159.93 per share. | 05 Jun 2026 | 98,663 | 117,047 (0%) | 0% | 159.9 | 15,779,006 | Common Stock |
| Acacia Research Corp | Jason W. Soncini | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 93,049 | 284,600 (0%) | 0% | 0 | ACTG Common Stock | |
| EQT | Toby Z. Rice | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 54.17 per share. | 05 Jun 2026 | 86,472 | 2,345,435 (0%) | 0% | 54.2 | 4,684,188 | Common Stock |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.44 per share. | 05 Jun 2026 | 80,820 | 288,220 (0%) | 0% | 45.4 | 3,672,057 | Common Stock, $.25 Par Value |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 80,820 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Sale of securities on an exchange or to another person at price $ 79.46 per share. | 05 Jun 2026 | 80,820 | 207,400 (0%) | 0% | 79.5 | 6,422,038 | Common Stock, $.25 Par Value |
| UDR | Thomas W. Toomey | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 05 Jun 2026 | 80,000 | 810,455 (0%) | 0% | 39.3 | 3,140,008 | Common Stock |
| Worksport Ltd | Steven Rossi | Director, Chairman, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 05 Jun 2026 | 79,618 | 2,693,703 | - | 0.6 | 50,000 | Common Stock |
| General Mills | Jaime Montemayor | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,415 | 165,515 (0%) | 0% | 0 | Common Stock | |
| Prime Medicine Inc | Kaye Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Granite Point Mortgage Trust Inc | Stephen G. Kasnet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 66,929 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Stephen G. Kasnet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 66,929 | 205,495 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Daniel Zugelder | EVP, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 61,034 | 61,034 | - | - | Restricted Stock Units | |
| Digi Intl Inc | Ronald E. Konezny | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 60,654 | 0 | - | - | Employee Stock Option (right to buy) | |
| Digi Intl Inc | Ronald E. Konezny | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.53 per share. | 05 Jun 2026 | 60,654 | 649,955 (2%) | 0% | 21.5 | 1,305,881 | Common Stock |
| Acacia Research Corp | Robert Rasamny | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,285 | 102,366 (0%) | 0% | 0 | ACTG Common Stock | |
| Anteris Tech Global Corp | Matthew McDonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 05 Jun 2026 | 60,000 | 62,001 | - | 6.3 | 379,200 | Common Stock |
| Anteris Tech Global Corp | Matthew McDonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 0 | - | - | Stock options | |
| Coherus Biosciences Inc | Mats L. Wahlstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Rita A. Karachun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Ali J. Satvat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Lee N. Newcomer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Charles W. Newton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Jill O’Donnell-Tormey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Michael Lee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 53,383 | 108,382 | - | - | Restricted Stock Units | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 53,383 | 257,771 (0%) | 0% | - | Common Stock | |
| General Mills | Karen Wilson Thissen | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 51,283 | 84,280 (0%) | 0% | 0 | Common Stock | |
| Hinge Health Inc (Class A) | Gabriel Mecklenburg | Director, Exec. Chairman & Co-Founder | 05 Jun 2026 | 50,000 | 50,000 | - | 0 | Class A Common Stock | ||
| Hinge Health Inc (Class A) | Gabriel Mecklenburg | Director, Exec. Chairman & Co-Founder | 05 Jun 2026 | 50,000 | 1,727,341 | - | - | Class B Common Stock | ||
| National Vision Holdings Inc | Michael J. Nicholson | Director | Purchase of securities on an exchange or from another person at price $ 15.52 per share. | 05 Jun 2026 | 50,000 | 50,000 (0%) | 0% | 15.5 | 776,000 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.57 per share. | 05 Jun 2026 | 49,716 | 2,063,203 (2%) | 0% | 125.6 | 6,242,788 | Common Stock |
| Texas Cap Bancshares Inc | Rob C. Holmes | Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 101.22 per share. | 05 Jun 2026 | 49,500 | 167,635 (0%) | 0% | 101.2 | 5,010,390 | Common Stock |
| Hinge Health Inc (Class A) | Gabriel Mecklenburg | Director, Exec. Chairman & Co-Founder | Sale of securities on an exchange or to another person at price $ 65.53 per share. | 05 Jun 2026 | 49,470 | 530 | - | 65.5 | 3,241,863 | Class A Common Stock |
| Texas Cap Bancshares Inc | Rob C. Holmes | Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 101.88 per share. | 05 Jun 2026 | 49,100 | 217,135 (0%) | 0% | 101.9 | 5,002,308 | Common Stock |
| Acacia Research Corp | Jason W. Soncini | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.62 per share. | 05 Jun 2026 | 48,985 | 235,615 (0%) | 0% | 4.6 | 226,311 | ACTG Common Stock |
| Dynatrace Inc | Bernd Greifeneder | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 48,590 | 48,590 | - | - | Restricted Stock Units | |
| Northwest Bancshares Inc | Steven Chad Ballard | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 47,217 | 47,217 (0%) | 0% | 0 | Northwest Bancshares, Inc. Common Stock | |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Sale of securities on an exchange or to another person at price $ 121.00 per share. | 05 Jun 2026 | 45,073 | 865,633 (1%) | 0% | 121 | 5,453,833 | Class A Common Stock |
| W & T Offshore Inc | William J. Williford | EVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 45,000 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | William J. Williford | EVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 45,000 | 422,880 (0%) | 0% | - | Common Stock | |
| Innio NV | Lee C. Banks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 44,445 | 44,445 | - | 0 | Common Shares | |
| Innio NV | Christopher Yetman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 44,445 | 44,445 | - | 0 | Common Shares | |
| Infinity Natural Resources Inc (Class A) | William J. Quinn | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.19 per share. | 05 Jun 2026 | 44,000 | 54,503 | - | 13.2 | 580,206 | Class A Common Stock |
| Granite Point Mortgage Trust Inc | Hope B. Woodhouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 43,799 | 138,222 (0%) | 0% | - | Common Stock | |
| Granite Point Mortgage Trust Inc | Hope B. Woodhouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 43,799 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Tanuja M. Dehne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 43,307 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Tanuja M. Dehne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 43,307 | 120,459 (0%) | 0% | - | Common Stock | |
| KinderCare Learning Companies Inc | Jean S. Desravines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 43,210 | 69,513 | - | 0 | Common Stock | |
| Granite Point Mortgage Trust Inc | Sheila K. McGrath | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 42,814 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Sheila K. McGrath | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 42,814 | 107,416 (0%) | 0% | - | Common Stock | |
| Accel Entertainment Inc (Class A1) | Derek Harmer | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 42,085 | 42,085 | - | - | Restricted Stock Unit (RSU) | |
| Westrock Coffee Co | Kenneth M. Parent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 41,992 | 202,943 | - | 0 | COMMON STOCK | |
| W & T Offshore Inc | Tracy W. Krohn | Director, Chairman, CEO & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 05 Jun 2026 | 41,974 | 1,344,979 (0%) | 0% | 3.7 | 155,304 | Common Stock |
| Granite Point Mortgage Trust Inc | Patrick G. Halter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 40,846 | 0 | - | - | Restricted Stock Units | |
| Granite Point Mortgage Trust Inc | Patrick G. Halter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 40,846 | 135,209 (0%) | 0% | - | Common Stock | |
| Granite Point Mortgage Trust Inc | Lazar Nikolic | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 40,846 | 93,648 (0%) | 0% | - | Common Stock | |
| Granite Point Mortgage Trust Inc | Lazar Nikolic | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 40,846 | 0 | - | - | Restricted Stock Units | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | 05 Jun 2026 | 40,000 | 923,735 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | 05 Jun 2026 | 40,000 | 4,263,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | Sale of securities on an exchange or to another person at price $ 3.62 per share. | 05 Jun 2026 | 40,000 | 883,735 | - | 3.6 | 144,800 | Class A Common Stock |
| AST SpaceMobile Inc (Class A) | Huiwen Yao | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 96.37 per share. | 05 Jun 2026 | 40,000 | 34,750 | - | 96.4 | 3,854,800 | Class A Common Stock |
| Climb Bio Inc | Douglas E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Andrew Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Judith A. Dunn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Sunshine Silver Mining | Anna El-Erian | Director | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 05 Jun 2026 | 40,000 | 48,929 | - | 13.5 | 540,000 | Common Stock |
| Pulmonx Corp | Dana G. Mead | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 139,714 | - | 0 | Common Stock | |
| Pulmonx Corp | Daniel P. Florin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 133,910 | - | 0 | Common Stock | |
| Pulmonx Corp | Thomas W. Burns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 113,399 | - | 0 | Common Stock | |
| Pulmonx Corp | Georgia Garinois-Melenikiotou | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 139,714 | - | 0 | Common Stock | |
| Pulmonx Corp | Richard M. Ferrari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 127,024 | - | 0 | Common Stock | |
| Pulmonx Corp | Tiffany Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 40,000 | 115,199 | - | 0 | Common Stock | |
| Digi Intl Inc | Ronald E. Konezny | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.78 per share. | 05 Jun 2026 | 39,776 | 610,179 (2%) | 0% | 66.8 | 2,656,241 | Common Stock |
| Bluelinx Hldgs Inc | Shyam K. Reddy | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 39,761 | 39,761 | - | - | Restricted Stock Units | |
| Anteris Tech Global Corp | Matthew McDonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.83 per share. | 05 Jun 2026 | 39,595 | 22,406 | - | 9.8 | 389,219 | Common Stock |
| General Mills | Jacqueline Williams-Roll | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 39,216 | 59,048 (0%) | 0% | 0 | Common Stock | |
| Dynatrace Inc | Stephen A. McMahon | EVP, Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 37,924 | 37,924 | - | - | Restricted Stock Units | |
| VAALCO Energy Inc | Ronald Yeats Bain | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.29 per share. | 05 Jun 2026 | 37,335 | 447,007 (0%) | 0% | 5.3 | 197,502 | Common Stock |
| KinderCare Learning Companies Inc | Michael M. Nuzzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 37,038 | 83,943 | - | 0 | Common Stock | |
| KinderCare Learning Companies Inc | Christine Deputy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 37,038 | 58,943 | - | 0 | Common Stock | |
| KinderCare Learning Companies Inc | Alyssa Sue Waxenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 37,038 | 56,745 | - | 0 | Common Stock | |
| Innio NV | Lee C. Banks | Director | Purchase of securities on an exchange or from another person at price $ 27.00 per share. | 05 Jun 2026 | 37,037 | 37,037 | - | 27 | 999,999 | Common Shares |
| Innio NV | Christopher Yetman | Director | Purchase of securities on an exchange or from another person at price $ 27.00 per share. | 05 Jun 2026 | 37,037 | 37,037 | - | 27 | 999,999 | Common Shares |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 36,515 | 60,544 | - | - | Performance Restricted Stock Units (Financial) | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 36,515 | 267,124 (0%) | 0% | - | Common Stock | |
| Dyne Therapeutics Inc | Brian S. Posner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Dirk Kersten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Carlo Incerti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 35,152 | 35,152 | - | - | Stock option (right to buy) | |
| BrightSpring Health Services Inc | Lisa Nalley | See Remarks | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 35,000 | 131,948 | - | 58.8 | 2,056,250 | Common Stock |
| BrightSpring Health Services Inc | Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 35,000 | 41,909 | - | - | Stock Options (Right to Buy) | |
| BrightSpring Health Services Inc | Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 35,000 | 166,948 | - | 6.4 | 222,950 | Common Stock |
| BrightSpring Health Services Inc | Jennifer Phipps | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 05 Jun 2026 | 35,000 | 285,224 | - | 6.4 | 222,950 | Common Stock |
| BrightSpring Health Services Inc | Jennifer Phipps | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.75 per share. | 05 Jun 2026 | 35,000 | 250,224 | - | 58.8 | 2,056,250 | Common Stock |
| BrightSpring Health Services Inc | Jennifer Phipps | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 35,000 | 55,708 | - | - | Stock Options (Right to Buy) | |
| Snowflake Inc (Class A) | Michael L. Speiser | Director | Sale of securities on an exchange or to another person at price $ 245.21 per share. | 05 Jun 2026 | 34,005 | 1,199,269 | - | 245.2 | 8,338,230 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.33 per share. | 05 Jun 2026 | 33,843 | 2,029,360 (2%) | 0% | 126.3 | 4,275,261 | Common Stock |
| W.W. Grainger | Neil S. Novich | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 33,644 | 0 | - | - | Deferred Stock Units | |
| W.W. Grainger | Neil S. Novich | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 33,644 | 33,644 | - | - | Deferred Stock Units | |
| Western Union Co | Giovanni Angelini | President Europe, Africa, MEPA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 33,423 | 344,715 (0%) | 0% | 0 | Common Stock | |
| Western Union Co | Giovanni Angelini | President Europe, Africa, MEPA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 33,423 | 378,138 (0%) | 0% | 0 | Common Stock | |
| eBay | Cornelius Boone | SVP, Chief People Officer | Sale of securities on an exchange or to another person at price $ 109.69 per share. | 05 Jun 2026 | 31,100 | 63,681 (0%) | 0% | 109.7 | 3,411,359 | Common Stock |
| Wrap Tech Inc | Scot Cohen | Director, Executive Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,435 | 2,008,469 (6%) | 0% | 0 | Common Stock | |
| Camden Property - REIT | Richard J. Campo | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 112.42 per share. | 05 Jun 2026 | 30,000 | 297,437 (0%) | 0% | 112.4 | 3,372,600 | Common Shares |
| Coherus Biosciences Inc | Mats L. Wahlstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Rita A. Karachun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Ali J. Satvat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Lee N. Newcomer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Charles W. Newton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Jill O’Donnell-Tormey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Michael Lee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Bluelinx Hldgs Inc | Shyam K. Reddy | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 29,821 | 29,821 | - | - | Restricted Stock Units | |
| Arista Networks | Andy Bechtolsheim | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 153.79 per share. | 05 Jun 2026 | 29,438 | 294,411 (0%) | 0% | 153.8 | 4,527,158 | Common Stock |
| Teads Holding Co. | David Kostman | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.22 per share. | 05 Jun 2026 | 28,411 | 1,525,026 | - | 1.2 | 34,661 | Common Stock |
| Acacia Research Corp | Robert Rasamny | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.62 per share. | 05 Jun 2026 | 28,390 | 73,976 (0%) | 0% | 4.6 | 131,162 | ACTG Common Stock |
| Inogen Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 104,966 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Elizabeth A. Mora | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 107,261 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Heather D. Rider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 116,282 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Glenn S. Boehnlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 104,966 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Mary Katherine Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 104,966 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Vafa Jamali | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 43,081 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Mira Kirti Sahney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 28,081 | 67,805 (0%) | 0% | 0 | Common Stock | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.19 per share. | 05 Jun 2026 | 27,162 | 230,609 (0%) | 0% | 42.2 | 1,145,965 | Common Stock |
| Arista Networks | Andy Bechtolsheim | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 158.88 per share. | 05 Jun 2026 | 27,027 | 215,710 (0%) | 0% | 158.9 | 4,294,071 | Common Stock |
| Granite Point Mortgage Trust Inc | Stephen G. Kasnet | Director | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 05 Jun 2026 | 26,772 | 178,723 (0%) | 0% | 1.5 | 39,623 | Common Stock |
| Cars.com | Scott E. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 25,478 | 218,866 (0%) | 0% | 0 | Common Stock | |
| Perrigo Co PLC | Patrick Lockwood-Taylor | Former CEO and director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.83 per share. | 05 Jun 2026 | 25,230 | 136,076 (0%) | 0% | 10.8 | 273,241 | Ordinary Shares |
| Perrigo Co PLC | Patrick Lockwood-Taylor | Former CEO and director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 25,230 | 50,458 | - | - | Restricted Stock Units | |
| Montrose Environmental Grp Inc | Peter M. Graham | Director | Purchase of securities on an exchange or from another person at price $ 17.19 per share. | 05 Jun 2026 | 25,140 | 256,689 | - | 17.2 | 432,157 | Common Stock |
| Krispy Kreme Inc | Bernardo Hees | Director | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 05 Jun 2026 | 25,002 | 1,574,635 | - | 3.5 | 87,167 | Common Stock |
| Tango Therapeutics Inc | Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Globus Medical Inc (Class A) | David D. Davidar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 25,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David D. Davidar | Director | Sale of securities on an exchange or to another person at price $ 80.76 per share. | 05 Jun 2026 | 25,000 | 510,175 (0%) | 0% | 80.8 | 2,019,073 | Class A Common Stock |
| Globus Medical Inc (Class A) | David D. Davidar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.27 per share. | 05 Jun 2026 | 25,000 | 535,175 (0%) | 0% | 26.3 | 656,750 | Class A Common Stock |
| Eos Energy Enterprises Inc (Class A) | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 24,289 | 24,289 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc (Class A) | Joseph Nigro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 24,289 | 24,289 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Joseph Bryan Armour | Sr Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 24,203 | 24,203 | - | - | Restricted Stock Unit | |
| VAALCO Energy Inc | Thor Pruckl | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.29 per share. | 05 Jun 2026 | 24,168 | 516,155 (0%) | 0% | 5.3 | 127,849 | Common Stock |
| GBank Fin Holdings Inc | Charles W. Griege | Director | Purchase of securities on an exchange or from another person at price $ 29.00 per share. | 05 Jun 2026 | 24,000 | 368,289 | - | 29 | 696,000 | Common Stock |
| Recursion Pharma Inc (Class A) | Najat Khan | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 3.58 per share. | 05 Jun 2026 | 23,588 | 2,175,796 | - | 3.6 | 84,459 | Class A Common Stock |
| Dynatrace Inc | Stephen A. McMahon | EVP, Chief Customer Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 23,285 | 27,240 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Stephen A. McMahon | EVP, Chief Customer Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 23,285 | 69,853 | - | - | Restricted Stock Units | |
| CryoPort Inc | Ramkumar Mandalam | Director | Sale of securities on an exchange or to another person at price $ 15.44 per share. | 05 Jun 2026 | 23,214 | 67,894 (0%) | 0% | 15.4 | 358,452 | Common Stock |
| Montana Tech Corp (Class A) | Stephen S. Pang | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 23,125 | 46,250 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Stephen S. Pang | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 23,125 | 54,185 | - | 0 | Class A Common Stock | |
| Montana Tech Corp (Class A) | Chad MacDonald | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 23,125 | 46,250 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Chad MacDonald | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 23,125 | 51,387 | - | 0 | Class A Common Stock | |
| NRG Energy | Woo-Sung Bruce Chung | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,328 | 101,591 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| NRG Energy | Woo-Sung Bruce Chung | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,328 | 0 | - | - | Relative Performance Stock Units | |
| Microvision Inc | Simon Biddiscombe | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 407,256 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Simon Biddiscombe | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 0 | - | - | Restricted Stock Units | |
| Microvision Inc | Robert P. Carlile | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 0 | - | - | Restricted Stock Units | |
| Microvision Inc | Robert P. Carlile | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 560,706 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Jeffrey A. Herbst | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 0 | - | - | Restricted Stock Units | |
| Microvision Inc | Jeffrey A. Herbst | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 280,919 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Peter Schabert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 0 | - | - | Restricted Stock Units | |
| Microvision Inc | Peter Schabert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 168,478 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Jada Smith M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 176,550 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Jada Smith M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 22,007 | 0 | - | - | Restricted Stock Units | |
| Wrap Tech Inc | Scot Cohen | Director, Executive Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 21,740 | 6,584,979 (22%) | 0% | 0 | Common Stock | |
| Teva- pharma Ind Ltd (ADR) | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 21,739 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 21,739 | 448,011 (0%) | 0% | - | Ordinary Shares | |
| Nextracker Inc (Class A) | Daniel S. Shugar | Director, Chief Executive Officer | Other type of transaction at price $ 144.73 per share. | 05 Jun 2026 | 21,402 | 911,679 | - | 144.7 | 3,097,511 | Common Stock |
| Eos Energy Enterprises Inc (Class A) | Alexander Dimitrief | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 21,253 | 21,253 | - | - | Restricted Stock Units | |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 20,417 | 40,834 | - | - | Employee Stock Option (Right to Buy) | |
| EchoStar Corp (Class A) | Hamid Akhavan | Director, CEO, EchoStar Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.04 per share. | 05 Jun 2026 | 20,417 | 886,050 (1%) | 0% | 14.0 | 286,655 | Class A Common Stock |
| Charles River Labs | James C. Foster | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | James C. Foster | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 20,000 | 106,596 (0%) | 0% | 0 | Common Stock | |
| One Stop Systems Inc | Michael Knowles | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.89 per share. | 05 Jun 2026 | 19,675 | 607,383 (3%) | 0% | 16.9 | 332,311 | Common Stock |
| AerSale Corp | Andrew C. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 19,623 | 80,528 | - | 0 | Common Stock | |
| AerSale Corp | Carol A. Dibattiste | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 19,623 | 43,880 | - | 0 | Common Stock | |
| AerSale Corp | Robert B. Nichols | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 19,623 | 3,503,077 | - | 0 | Common Stock | |
| AerSale Corp | Judith A. Fedder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 19,623 | 81,798 | - | 0 | Common Stock | |
| AerSale Corp | Thomas Mullins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 19,623 | 46,424 | - | 0 | Common Stock | |
| AerSale Corp | Thomas D. Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 19,623 | 43,880 | - | 0 | Common Stock | |
| World Kinect Corp | Michael J. Kasbar | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 05 Jun 2026 | 19,300 | 1,021,450 (1%) | 0% | 30.2 | 582,372 | Common Stock |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 19,180 | 51,606 | - | - | Employee Stock Option (Right to Buy) | |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Sale of securities on an exchange or to another person at price $ 79.46 per share. | 05 Jun 2026 | 19,180 | 207,400 (0%) | 0% | 79.5 | 1,524,035 | Common Stock, $.25 Par Value |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.48 per share. | 05 Jun 2026 | 19,180 | 226,580 (0%) | 0% | 59.5 | 1,140,922 | Common Stock, $.25 Par Value |
| Viant Tech Inc (Class A) | Lawrence J. Madden | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.24 per share. | 05 Jun 2026 | 18,663 | 499,201 | - | 12.2 | 228,484 | Class A Common Stock |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.19 per share. | 05 Jun 2026 | 18,579 | 248,545 (0%) | 0% | 42.2 | 783,848 | Common Stock |
| Arista Networks | Andy Bechtolsheim | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.74 per share. | 05 Jun 2026 | 18,376 | 242,737 (0%) | 0% | 157.7 | 2,898,674 | Common Stock |
| Cars.com | Jill A. Greenthal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,267 | 127,545 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Thomas Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,267 | 95,497 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Donald A. McGovern | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,267 | 110,900 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Bryan J. Wiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,267 | 108,211 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Bala Subramanian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,267 | 126,578 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Jenell R. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,267 | 87,745 (0%) | 0% | 0 | Common Stock | |
| Eos Energy Enterprises Inc (Class A) | Gregory S. Nixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,217 | 18,217 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc (Class A) | David J. Urban | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,217 | 18,217 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc (Class A) | Claude Demby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 18,217 | 18,217 | - | - | Restricted Stock Units | |
| Microvision Inc | Laura J. Peterson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 18,005 | 109,601 (0%) | 0% | 0 | Common Stock | |
| Microvision Inc | Laura J. Peterson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 18,005 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | William J. Williford | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 05 Jun 2026 | 17,708 | 405,172 (0%) | 0% | 3.7 | 65,520 | Common Stock |
| Global Business Travel Grp Inc (Class A) | James Peter Bush | Director | Sale of securities on an exchange or to another person at price $ 9.36 per share. | 05 Jun 2026 | 17,500 | 120,526 | - | 9.4 | 163,800 | Class A Common Stock |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 17,145 | 0 | - | - | Performance Restricted Stock Units (Financial) | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 17,145 | 186,845 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Peter Radovich | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 16,988 | 48,012 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Peter Radovich | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.19 per share. | 05 Jun 2026 | 16,988 | 57,260 (0%) | 0% | 19.2 | 326,000 | Common Stock |
| Bandwidth Inc (Class A) | Richard Brandon Asbill | General Counsel | Sale of securities on an exchange or to another person at price $ 72.59 per share. | 05 Jun 2026 | 16,884 | 3,000 (0%) | 0% | 72.6 | 1,225,569 | Class A Common Stock |
| Accel Entertainment Inc (Class A1) | Christie Kozlik | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,851 | 16,851 | - | - | Restricted Stock Unit (RSU) | |
| Arcutis Biotherapeutics Inc | Keith R. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Terrie Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Neha Krishnamohan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Sue-Jean Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,667 | 16,667 | - | - | Stock Option (right to buy) | |
| Edgewise Therapeutics Inc | Jonathan C. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,377 | 16,377 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Christopher Nathan Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,377 | 16,377 | - | - | Stock Options (Right to buy) | |
| Edgewise Therapeutics Inc | Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,377 | 16,377 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Laura A. Brege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,377 | 16,377 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Peter A. Thompson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,377 | 16,377 | - | - | Stock Option (Right to Buy) | |
| Dynatrace Inc | Daniel Zugelder | EVP, Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 16,177 | 59,593 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Daniel Zugelder | EVP, Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 16,177 | 32,843 | - | - | Restricted Stock Units | |
| Arista Networks | Andy Bechtolsheim | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 156.93 per share. | 05 Jun 2026 | 16,082 | 261,113 (0%) | 0% | 156.9 | 2,523,737 | Common Stock |
| CryoPort Inc | Linda Baddour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,077 | 16,077 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,077 | 16,077 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Ramkumar Mandalam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,077 | 16,077 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Daniel M. Hancock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,077 | 16,077 | - | - | Option (Right to Buy Common Stock) | |
| Verrica Pharma Inc | Mark A. Prygocki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Verrica Pharma Inc | Gavin Corcoran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Verrica Pharma Inc | Diem Nguyen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Verrica Pharma Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| NRG Energy | Virginia Kinney | Exec VP, Chief Admin Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,948 | 71,473 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| NRG Energy | Virginia Kinney | Exec VP, Chief Admin Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,948 | 0 | - | - | Relative Performance Stock Units | |
| Dynatrace Inc | Stephen A. McMahon | EVP, Chief Customer Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,926 | 30,606 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Stephen A. McMahon | EVP, Chief Customer Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,926 | 47,776 | - | - | Performance Restricted Stock Units (Financial) | |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 117.94 per share. | 05 Jun 2026 | 15,800 | 753,281 (1%) | 0% | 117.9 | 1,863,520 | Common Stock |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Director, Interim CEO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,625 | 569,130 (0%) | 0% | 0 | Common Stock | |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Director, Interim CEO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,625 | 109,382 | - | - | Restricted Stock Units | |
| Flex Ltd | Scott Offer | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 154.22 per share. | 05 Jun 2026 | 15,601 | 78,621 (0%) | 0% | 154.2 | 2,405,977 | Ordinary Shares |
| Lucid Grp Inc | Marc Winterhoff | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.68 per share. | 05 Jun 2026 | 15,263 | 339,802 | - | 5.7 | 86,694 | Class A Common Stock |
| CNB Fin Corp (PA) | Francis X. Straub | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 15,169 | 22,805 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Andy Bechtolsheim | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 154.56 per share. | 05 Jun 2026 | 15,140 | 279,271 (0%) | 0% | 154.6 | 2,340,010 | Common Stock |
| General Mills | Ricardo Fernandez | Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,083 | 77,365 (0%) | 0% | 0 | Common Stock | |
| General Mills | Elizabeth Mascolo | Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,083 | 35,625 (0%) | 0% | 0 | Common Stock | |
| ARKO Corp (Class A) | Maury Bricks | General Counsel/Secretary | Sale of securities on an exchange or to another person at price $ 7.69 per share. | 05 Jun 2026 | 15,000 | 182,841 | - | 7.7 | 115,350 | Common Stock, par value $0.0001 per share |
| Neurocrine Biosciences Inc | Stephen A. Sherwin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 0 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences Inc | Stephen A. Sherwin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.64 per share. | 05 Jun 2026 | 15,000 | 30,860 (0%) | 0% | 53.6 | 804,600 | Common Stock |
| Arcturus Therapeutics Holdings Inc | James F. Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Peter C. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Moncef M. Slaoui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Edward W. Holmes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | John H. Markels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Jing L. Marantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Dynatrace Inc | Bernd Greifeneder | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,883 | 951,905 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Bernd Greifeneder | EVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,883 | 30,216 | - | - | Restricted Stock Units | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,814 | 59,257 | - | - | Restricted Stock Units | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,814 | 204,802 (0%) | 0% | - | Common Stock | |
| Samsara Inc (Class A) | Dominic Phillips | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 05 Jun 2026 | 14,747 | 934,375 | - | 35.1 | 517,214 | Class A Common Stock |
| Viant Tech Inc (Class A) | Lawrence J. Madden | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.10 per share. | 05 Jun 2026 | 14,670 | 484,531 | - | 12.1 | 177,479 | Class A Common Stock |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,584 | 25,521 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Sale of securities on an exchange or to another person at price $ 2.93 per share. | 05 Jun 2026 | 14,584 | 62,586 (0%) | 0% | 2.9 | 42,737 | Common Stock |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.78 per share. | 05 Jun 2026 | 14,584 | 77,170 (0%) | 0% | 0.8 | 11,448 | Common Stock |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,504 | 0 | - | - | Performance Restricted Stock Units (rTSR) | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,504 | 211,768 (0%) | 0% | - | Common Stock | |
| Teva- pharma Ind Ltd (ADR) | Gerald M. Lieberman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 130,149 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Gerald M. Lieberman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Elstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 2,118,455 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Elstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Rosemary A. Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Rosemary A. Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 127,739 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Perry D. Nisen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Perry D. Nisen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 119,807 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Tal Zaks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Tal Zaks | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 73,264 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 119,807 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Ronit Satchi-Fainaro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Ronit Satchi-Fainaro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 112,401 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Chen Lichtenstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Chen Lichtenstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 14,492 | 19,296 (0%) | 0% | - | Ordinary Shares | |
| Dynatrace Inc | Daniel Zugelder | EVP, Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 13,918 | 41,518 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Daniel Zugelder | EVP, Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 13,918 | 0 | - | - | Performance Restricted Stock Units (Financial) | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 128.25 per share. | 05 Jun 2026 | 13,787 | 2,014,473 (2%) | 0% | 128.3 | 1,768,198 | Common Stock |
| EverCommerce Inc | Eric Remer | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.20 per share. | 05 Jun 2026 | 13,772 | 2,776,132 | - | 9.2 | 126,702 | Common Stock |
| EverCommerce Inc | Eric Remer | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.20 per share. | 05 Jun 2026 | 13,645 | 2,762,487 | - | 9.2 | 125,534 | Common Stock |
| Quantinuum Inc Ordinary | Michal Stepniak | Director | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 05 Jun 2026 | 13,333 | 13,333 | - | 60 | 799,980 | Class A Common Stock |
| Teva- pharma Ind Ltd (ADR) | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 13,043 | 39,130 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 13,043 | 1,183,682 (0%) | 0% | - | Ordinary Shares | |
| Quantinuum Inc Ordinary | Vimal Kapur | Director | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | 60 | 780,000 | Class A Common Stock |
| CRISPR Therapeutics AG | Maria Fardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Sandesh Mahatme | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Briggs W. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | John T. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Katherine A. High | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Douglas A. Treco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | H. Edward Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| CRISPR Therapeutics AG | Christian Rommel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Snowflake Inc (Class A) | Michael L. Speiser | Director | Sale of securities on an exchange or to another person at price $ 245.21 per share. | 05 Jun 2026 | 12,973 | 428,093 | - | 245.2 | 3,181,057 | Common Stock |
| Perrigo Co PLC | Patrick Lockwood-Taylor | Former CEO and director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.83 per share. | 05 Jun 2026 | 12,906 | 123,170 (0%) | 0% | 10.8 | 139,772 | Ordinary Shares |
| First Advantage Corp | Judith Sim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 12,805 | 73,950 | - | 0 | Common Stock | |
| First Advantage Corp | James L. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 12,805 | 61,765 | - | 0 | Common Stock | |
| First Advantage Corp | Susan R. Bell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 12,805 | 73,950 | - | 0 | Common Stock | |
| First Advantage Corp | Bridgett R. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 12,805 | 62,572 | - | 0 | Common Stock | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 12,607 | 0 | - | - | Restricted Stock Units | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 12,607 | 190,728 (0%) | 0% | - | Common Stock | |
| Dynatrace Inc | Stephen A. McMahon | EVP, Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.19 per share. | 05 Jun 2026 | 12,560 | 14,680 (0%) | 0% | 42.2 | 529,906 | Common Stock |
| Bridgewater Bancshares Inc | Nick L. Place | CHIEF BANKING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 12,500 | 127,500 | - | - | option to buy | |
| Bridgewater Bancshares Inc | Nick L. Place | CHIEF BANKING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.47 per share. | 05 Jun 2026 | 12,500 | 152,122 (0%) | 0% | 7.5 | 93,375 | Common Stock |
| Montana Tech Corp (Class A) | Matthew B. Jore | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 12,500 | 25,000 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Matthew B. Jore | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 12,500 | 7,751,749 | - | 0 | Class A Common Stock | |
| VAALCO Energy Inc | Matthew R. Powers | EVP, Gen. Counsel & Corp. Sect | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.29 per share. | 05 Jun 2026 | 12,340 | 233,754 (0%) | 0% | 5.3 | 65,279 | Common Stock |
| Bandwidth Inc (Class A) | Richard Brandon Asbill | General Counsel | Sale of securities on an exchange or to another person at price $ 71.27 per share. | 05 Jun 2026 | 12,330 | 19,884 (0%) | 0% | 71.3 | 878,807 | Class A Common Stock |
| Flex Ltd | Scott Offer | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 152.97 per share. | 05 Jun 2026 | 12,249 | 94,222 (0%) | 0% | 153.0 | 1,873,754 | Ordinary Shares |
| NRG Energy | Woo-Sung Bruce Chung | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.20 per share. | 05 Jun 2026 | 12,142 | 89,592 (0%) | 0% | 129.2 | 1,568,746 | Common Stock, par value $.01 per share |
| Buckle Inc | Brett P. Milkie | SVP Leasing | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2026 | 12,000 | 95,970 (0%) | 0% | 0 | Common Stock | |
| Prudential PLC (ADR) | Douglas Jardine Flint | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 100.34 per share. | 05 Jun 2026 | 12,000 | 32,000 (0%) | 0% | 100.3 | 1,204,068 | Ords 0.05p |
| Nature`s Sunshine Products Inc | Bryant J. Yates | EVP & President, Europe | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 05 Jun 2026 | 11,968 | 77,446 (0%) | 0% | 19.9 | 238,163 | Common Shares |
| InnovAge Holding Corp | Patrick Blair | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 05 Jun 2026 | 11,881 | 697,191 | - | 7.3 | 86,731 | Common Stock, $0.001 par value |
| Moderna | James M. Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 11,798 | 71,392 (0%) | 0% | - | Common Stock | |
| Moderna | James M. Mock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 11,798 | 117,976 | - | - | Restricted Stock Units | |
| Surgery Partners Inc | Brent Turner | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 86,594 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Surgery Partners Inc | Clifford G. Adlerz | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 69,104 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Surgery Partners Inc | Lloyd H. Dean | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 11,670 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Surgery Partners Inc | Blair E. Hendrix | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 18,531 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Surgery Partners Inc | Laura L. Forese | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 18,531 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 56,843 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Surgery Partners Inc | John A. Deane | Director | Grant, award, or other acquisition of securities at price $ 13.71 per share. | 05 Jun 2026 | 11,670 | 45,922 (0%) | 0% | 13.7 | 159,996 | Common Stock |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 11,554 | 46,218 | - | - | Performance Restricted Stock Units (Financial) | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2026 | 11,554 | 195,867 (0%) | 0% | - | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.